期刊文献+

两株具有潜在益生作用的人源链球菌的安全性评价 被引量:7

Safety evaluation of two strains of human Streptococcus with potential probiotics
下载PDF
导出
摘要 对分离于健康儿童口咽部的2株对金黄色葡萄球菌等常见致病菌具有广谱拮抗作用的甲型链球菌菌株1-4和4-2的安全性进行评价,为其作为呼吸道益生菌产品的研发和制备提供安全性依据。通过给予SPF级小鼠口服含有菌株1-4和4-2不同剂量的菌液的急性毒性实验以及耐药性的测定,观察动物是否出现死亡,急性毒性体征,细菌移位生长等情况。未发现动物死亡情况,实验组的体重变化采食量以及脏器指数均与对照组无显著差异,未有细菌移位生长的现象发生。菌株1-4和4-2均对9种常见抗生素的检测结果为敏感,其中菌株4-2对红霉素具有抗性。菌株1-4和4-2的安全性评价初步显示对小鼠无毒副作用,具有良好的安全性,可以作为呼吸道微生态制剂等产品的备用菌株。 The safety of strains 1-4 and 4-2,two potential probiotics isolated from the oropharynx of healthy children with broad-spectrum antagonism against Staphylococcus aureus and other common pathogenic bacteria,were evaluated so as to provide safety basis for the development and preparation of probiotics as respiratory tract products.The acute toxicity test and the determination of drug resistance of SPF mice with different doses of bacterial liquid containing strains 1-4 and 4-2 were conducted,and evaluation were made by observing death of the animals,signs of acute toxicity,bacterial translocation and growth,etc.Death of animals,or significant difference between the experimental group and the control group in weight change,food intake and organ index were not observed.Strains 1-4 and 4-2 were sensitive to 8 antibiotics tested and were resistant to cefotaxime and ceftriaxone,in addition strain 4-2 was also resistant to erythromycin.The safety evaluation of strains 1-4 and 4-2 showed that they were harmless to mice and had good safety,and could be used as backup strains for preparation of respiratory microecological and other products.
作者 王楠 田晗 张文晓 白筱翠 肖纯凌 WANG Nan;TIAN Han;ZHANG Wenxiao;BAI Xiaocui;XIAO Chunling(Department of Environmental Pollution and Health Sheng Yang,Shenyang Medical College,Shenyang 110034,China)
出处 《食品与发酵工业》 CAS CSCD 北大核心 2021年第5期12-16,共5页 Food and Fermentation Industries
基金 辽宁省科学技术厅项目(2017225076) 沈阳市科技局“重大科技研发项目”(18-400409) 沈阳医学院研究生创新基金项目(Y20190509)。
关键词 益生菌 急性毒性 耐药性 安全性评价 probiotics acute toxicity drug resistance safety evaluation
  • 相关文献

参考文献4

二级参考文献51

  • 1潘伟好,李平兰,孙承虎.双歧杆菌的药敏性及其质粒DNA的检测[J].食品科学,2005,26(6):81-86. 被引量:12
  • 2任玲,周宏,茅一平,郑雯.神经外科手术患者下呼吸道医院感染危险因素分析[J].实用全科医学,2006,4(3):261-262. 被引量:4
  • 3刘清泉.最具市场竞争力的益生菌发展现状及值得关注的几个问题[J].中国食品添加剂,2006,17(6):47-60. 被引量:3
  • 4李小珍,胡正路,苏健,韩艳萍,廖映玲.重症监护病房呼吸机相关性肺炎危险因素分析[J].实用全科医学,2007,5(6):503-504. 被引量:26
  • 5Mazmanian SK, Round JL, Kasper DL. A microbial symbiosis factor prevents intestinal inflammatory disease [J]. Nature, 2008, 453 (7195) : 620 -625.
  • 6Jia W, Li H, Zhao L, et al. Gut microbiota: a potential new territory for drug targeting[ J]. Nat Rev Drug Discov, 2008, 7 (2) : 123 - 129.
  • 7Martinez-Medina M, Aldeguer X, Gonzalez-Huix F, et al. Abnormal microbiota composition in the ileocolonic mucosa of Crohn's disease patients as revealed by polymerase chain reaction-denaturing gradient gel electrophoresis [ J ]. Inflamm Bowel Dis, 2006, 12 (12) : 1136 -1145.
  • 8Madsen KL, Doyle JS, Tavernini MM, et al. Antibiotic therapy attenuates eolitls in interleukin 10 gene-deficient mice [J]. Gastroenterology, 2000, 118(6): 1094-1105.
  • 9Sellon RK, Tonkonogy S, Schuhz M, et al. Resident enteric bacteria are necessary for development of spontaneous colitis and immune system activation in interleukin-10-deficient mice [J]. Infect Immun, 1998, 66 ( 11 ) : 5224 - 5231.
  • 10Sood A, Midha V, Makharia GK, et al. The probiotic preparation, VSL#3 induces remission in patients with mild-to-moderately active ulcerative colitis [ J ]. Clin Gastroenterol Hepatol, 2009, 7 ( 11 ) : 1202 - 1209.

共引文献50

同被引文献59

引证文献7

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部